- Home
- RNXT vs ALAR Comparison
RNXT vs ALAR Comparison
Compare RNXT & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- ALAR
- Stock Information
- Founded
- RNXT 2012
- ALAR 2013
- Country
- RNXT United States
- ALAR Israel
- Employees
- RNXT N/A
- ALAR N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- ALAR Computer Software: Prepackaged Software
- Sector
- RNXT Health Care
- ALAR Technology
- Exchange
- RNXT Nasdaq
- ALAR Nasdaq
- Market Cap
- RNXT 44.6M
- ALAR 45.3M
- IPO Year
- RNXT 2021
- ALAR 2018
- Fundamental
- Price
- RNXT $1.30
- ALAR $12.30
- Analyst Decision
- RNXT Strong Buy
- ALAR Strong Buy
- Analyst Count
- RNXT 2
- ALAR 1
- Target Price
- RNXT $7.25
- ALAR $15.00
- AVG Volume (30 Days)
- RNXT 135.9K
- ALAR 162.4K
- Earning Date
- RNXT 08-12-2025
- ALAR 08-25-2025
- Dividend Yield
- RNXT N/A
- ALAR N/A
- EPS Growth
- RNXT N/A
- ALAR N/A
- EPS
- RNXT N/A
- ALAR 0.07
- Revenue
- RNXT $240,000.00
- ALAR $30,581,000.00
- Revenue This Year
- RNXT $3,104.65
- ALAR N/A
- Revenue Next Year
- RNXT $301.89
- ALAR $12.28
- P/E Ratio
- RNXT N/A
- ALAR $19.30
- Revenue Growth
- RNXT N/A
- ALAR 4.67
- 52 Week Low
- RNXT $0.75
- ALAR $5.45
- 52 Week High
- RNXT $1.69
- ALAR $37.19
- Technical
- Relative Strength Index (RSI)
- RNXT 53.41
- ALAR 55.68
- Support Level
- RNXT $1.29
- ALAR $13.20
- Resistance Level
- RNXT $1.38
- ALAR $14.63
- Average True Range (ATR)
- RNXT 0.07
- ALAR 1.01
- MACD
- RNXT -0.01
- ALAR -0.13
- Stochastic Oscillator
- RNXT 48.39
- ALAR 48.24
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.